News | March 07, 2024
Briefs: Zydus, Advanced Enzyme Technologies, Link Pharma Chem and ANVISA
ANVISA issues CGMP to Concord Biotech’s Unit I
ANVISA issues CGMP to Concord Biotech’s Unit I
The clearance of this audit marks the successful registration of 8 APIs with CADIFA
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
The approval allows it to market its products in the country
Patalganga plant received zero observation from USFDA earlier
Pharmaceutical manufacturer Wanbury Limited (WL) has strengthened its position in the Brazilian market after securing regulatory approval for Sertraline Form II from Brazil’s health regulator, ANVISA
CystoSmart, an AI tool designed to detect bladder tumors during screening and surveillance cystoscopy, is brand-agnostic and works with flexible, rigid, and single-use scopes
The Unit is approved by major regulators like EMA, Europe; Health Canada, Anvisa, Brazil and TGA, Australia
Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
Alembic receives EIR from USFDA for facility at Panelav
Subscribe To Our Newsletter & Stay Updated
